Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

$159.1M

Market Cap • 5/8/2025

2014

(11 years)

Founded

2021

(4 years ago)

IPO

NASDAQ

Listing Exchange

Flag of US

Scottsdale

Headquarters • Arizona